These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21104859)

  • 1. Bacterial overgrowth syndrome in myotonic muscular dystrophy is potentially treatable.
    Tarnopolsky MA; Pearce E; Matteliano A; James C; Armstrong D
    Muscle Nerve; 2010 Dec; 42(6):853-5. PubMed ID: 21104859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small intestinal bacterial overgrowth.
    Rana SV; Bhardwaj SB
    Scand J Gastroenterol; 2008; 43(9):1030-7. PubMed ID: 18609165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of small intestinal bacterial vergrowth in irritable bowel syndrome.
    Mann NS; Limoges-Gonzales M
    Hepatogastroenterology; 2009; 56(91-92):718-21. PubMed ID: 19621689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small intestinal bacterial overgrowth in systemic sclerosis.
    Marie I; Ducrotté P; Denis P; Menard JF; Levesque H
    Rheumatology (Oxford); 2009 Oct; 48(10):1314-9. PubMed ID: 19696066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small intestine bacterial overgrowth in irritable bowel syndrome: a retrospective study with rifaximin.
    Cuoco L; Salvagnini M
    Minerva Gastroenterol Dietol; 2006 Mar; 52(1):89-95. PubMed ID: 16554709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bacterial overgrowth syndrome].
    Stein JM; Schneider AR
    Z Gastroenterol; 2007 Jul; 45(7):620-8. PubMed ID: 17620228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small intestinal bacterial overgrowth produces symptoms in irritable bowel syndrome which are improved by rifaximin. A pilot study.
    Moraru IG; Portincasa P; Moraru AG; Diculescu M; Dumitraşcu DL
    Rom J Intern Med; 2013; 51(3-4):143-7. PubMed ID: 24620626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small intestinal bacterial overgrowth is associated to symptoms in irritable bowel syndrome. Evidence from a multicentre study in Romania.
    Moraru IG; Moraru AG; Andrei M; Iordache T; Drug V; Diculescu M; Portincasa P; Dumitrascu DL
    Rom J Intern Med; 2014; 52(3):143-50. PubMed ID: 25509557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome.
    Pimentel M; Chow EJ; Lin HC
    Am J Gastroenterol; 2000 Dec; 95(12):3503-6. PubMed ID: 11151884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breath testing for small intestinal bacterial overgrowth: maximizing test accuracy.
    Saad RJ; Chey WD
    Clin Gastroenterol Hepatol; 2014 Dec; 12(12):1964-72; quiz e119-20. PubMed ID: 24095975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic diarrhoea and diabetes mellitus: prevalence of small intestinal bacterial overgrowth.
    Virally-Monod M; Tielmans D; Kevorkian JP; Bouhnik Y; Flourie B; Porokhov B; Ajzenberg C; Warnet A; Guillausseau PJ
    Diabetes Metab; 1998 Dec; 24(6):530-6. PubMed ID: 9932220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small intestine bacterial overgrowth: an underdiagnosed cause of diarrhea in patients with pancreatic cancer.
    Bustillo I; Larson H; Saif MW
    JOP; 2009 Sep; 10(5):576-8. PubMed ID: 19734643
    [No Abstract]   [Full Text] [Related]  

  • 13. Chronic prostatitis and small intestinal bacterial overgrowth: effect of rifaximin.
    Weinstock LB; Geng B; Brandes SB
    Can J Urol; 2011 Aug; 18(4):5826-30. PubMed ID: 21854715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is small-bowel bacterial overgrowth an underdiagnosed disorder in children with gastrointestinal symptoms?
    Jones HF; Davidson GP; Brooks DA; Butler RN
    J Pediatr Gastroenterol Nutr; 2011 May; 52(5):632-4. PubMed ID: 21464754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bacterial overgrowth syndrome in the small intestine: pathogenesis, clinical significance and therapy tactics].
    Lykova EA; Bondarenko VM; Parfenov AI; Matsulevich TV
    Eksp Klin Gastroenterol; 2005; (6):51-7, 113. PubMed ID: 17378388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of small intestinal bacterial overgrowth in the clinical practice.
    Gabrielli M; D'Angelo G; Di Rienzo T; Scarpellini E; Ojetti V
    Eur Rev Med Pharmacol Sci; 2013; 17 Suppl 2():30-5. PubMed ID: 24443065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth.
    Nucera G; Gabrielli M; Lupascu A; Lauritano EC; Santoliquido A; Cremonini F; Cammarota G; Tondi P; Pola P; Gasbarrini G; Gasbarrini A
    Aliment Pharmacol Ther; 2005 Jun; 21(11):1391-5. PubMed ID: 15932370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small intestinal bacterial overgrowth as a cause for irritable bowel syndrome: guilty or not guilty?
    Aziz I; Törnblom H; Simrén M
    Curr Opin Gastroenterol; 2017 May; 33(3):196-202. PubMed ID: 28257307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication.
    Parodi A; Sessarego M; Greco A; Bazzica M; Filaci G; Setti M; Savarino E; Indiveri F; Savarino V; Ghio M
    Am J Gastroenterol; 2008 May; 103(5):1257-62. PubMed ID: 18422815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton pump inhibitor therapy use does not predispose to small intestinal bacterial overgrowth.
    Ratuapli SK; Ellington TG; O'Neill MT; Umar SB; Harris LA; Foxx-Orenstein AE; Burdick GE; Dibaise JK; Lacy BE; Crowell MD
    Am J Gastroenterol; 2012 May; 107(5):730-5. PubMed ID: 22334250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.